Qube Research & Technologies (QRT)
SRTA

Qube Research & Technologies (QRT)’s Strata Critical Medical Inc SRTA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-80,035
Closed -$385K – 3552
2025
Q4 		$385K Sell
80,035
-369,573
-82% -$1.79M ﹤0.01% 2875
2025
Q3 		$2.28M Buy
449,608
+150,984
+51% +$667K ﹤0.01% 2180
2025
Q2 		$1.2M Buy
298,624
+150,711
+102% +$491K ﹤0.01% 2396
2025
Q1 		$404K Buy
+147,913
New +$531K ﹤0.01% 2625
2024
Q1 		– Sell
-9,658
Closed -$34.1K – 4473
2023
Q4 		$34.1K Buy
+9,658
New +$27.7K ﹤0.01% 3393
2022
Q1 		– Sell
-21,380
Closed -$189K – 2461
2021
Q4 		$189K Buy
+21,380
New +$203K ﹤0.01% 1993
2021
Q2 		– Sell
-36,075
Closed -$371K – 2278
2021
Q1 		$371K Buy
+36,075
New +$502K 0.01% 1343

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SRTA Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Strata Critical Medical Inc (SRTA) in Q1 2026, closing a stake of 80,035 shares — an estimated $385K sold.

Qube Research & Technologies (QRT) first reported a position in SRTA in Q1 2021 and held it in 7 quarters. The position peaked at $2.28M in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Strata Critical Medical Inc position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 80,035 Strata Critical Medical Inc shares in Q1 2026, an estimated $385K.
  • Qube Research & Technologies (QRT) first reported a position in Strata Critical Medical Inc in Q1 2021 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s Strata Critical Medical Inc position peaked at $2.28M in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.